Anticoagulation in neonates and children: Pitfalls and dilemmas.
Anticoagulation in children is problematic for many reasons, related to the patient population as well as the anticoagulant drugs themselves. This paper describes the multitude of reasons why providing anticoagulation therapy in children is different from anticoagulation therapy in adults, and hence why dedicated paediatric anticoagulant services are the ideal structure to provide this service. The paper then describes the three most common anticoagulants used in children, and details specifically what is and is not known about them in the paediatric population. Finally the paper addresses the issue of how best to introduce newer anticoagulant drugs into the paediatric population. There remains much research to be done in this field, in the meantime clinicians need to carefully consider the evidence available to them and manage each individual patient accordingly.
Monagle
Paul
P
Department of Clinical Haematology, Royal Children's Hospital, Parkville, Victoria 3052, Australia. paul.monagle@rch.org.au
Newall
Fiona
F
Campbell
Janine
J
D000925:Anticoagulants / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D007223:Infant; D007231:Infant, Newborn
D000925:Anticoagulants